![[Patanjali Fake Ads Case] SC Reserves Verdict in Contempt Of Court Against Patanjali](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/04/patanjali1.jpg?resize=447%2C367&ssl=1)
Today (14th May): The Supreme Court of India reserved its verdict in the contempt of court case against Patanjali Ayurved and its owners, Baba Ramdev and Acharya Balkrishna, over misleading advertisements. The court dispensed with their personal appearance pending the submission of an affidavit detailing the steps taken to remove the misleading ads and recall suspended products. The case has drawn attention to larger issues, including unethical practices in modern medicine and the liability of celebrities endorsing misleading advertisements.
The Supreme Court Today (May 7th) questioned the Central government’s directive to AYUSH authorities, asking why they were instructed not to act against misleading advertisements under Rule 170 of the Drugs and Cosmetics Rules, 1945. The inquiry came during a hearing of a plea filed by the Indian Medical Association (IMA) against an alleged smear campaign by Patanjali Ayurved and its founders Baba Ramdev and Acharya Balkrishna, targeting the COVID-19 vaccination drive and modern medicine.
Today, 19th April, Baba Ramdev seeks Supreme Court intervention to suspend legal action on Bihar-Chhattisgarh FIR over his allopathy remarks. The court instructed him to include complainants as parties and scheduled the next hearing for July. Meanwhile, Delhi Medical Association and IMA continue their legal battle against Ramdev and Patanjali over the promotion of Coronil kits.
Today(on 16th April), The Supreme Court of India engaged with Patanjali promoters, Baba Ramdev and Acharya Balkrishna, to assess their sincerity over misleading ads disparaging modern medicine. The apology was deemed insufficient, and the case is adjourned till April 23 for further commitment demonstration. The Indian Medical Association filed the plea, citing a smear campaign against modern medicine and COVID-19 vaccination efforts.
The Supreme Court fined an intervention applicant Rs.10,000 for attempting to join a case against Patanjali Ayurved with misleading claims. The applicant alleged a quack doctor’s role in their mother’s death, but the court dismissed the application, warning against manipulating the legal process. Patanjali faced criticism for misleading advertisements and offered an unconditional apology.
Today, 10th April, The Supreme Court
scolded Uttarakhand’s drug licensing authority for failing to act against Patanjali Ayurved’s misleading ads, suspending three officers. The court also criticized Patanjali’s founders and the central AYUSH Ministry for not intervening. This follows a petition by the Indian Medical Association over misleading claims against COVID-19 and vaccines.
NEW DELHI: Today (10th April): The Supreme Court has rejected Patanjali’s unconditional apology for misleading advertisements, criticizing the company for deliberate disobedience. Justices Hima Kohli and Ahsanuddin Amanullah emphasized that leniency would not be shown. Patanjali founders acknowledged the breach, but the court disapproved, asserting the seriousness of the matter. The case pertains to false advertisements for Patanjali’s medicinal products.
Today (2nd April): The Supreme Court chastised Patanjali Ayurved for airing misleading advertisements for its ayurvedic products, demanding a more substantial apology for breaching its commitment. The Court expressed disappointment in Patanjali’s casual apology affidavit and hinted at perjury charges due to document discrepancies. Both Ramdev and Patanjali’s Managing Director are required to appear personally at the next hearing.